PacBio, in collaboration with the Agency for Science, Technology, and Research, or A*STAR, and Macrogen, announced the opening of a joint laboratory at A*STAR Genome Institute of Singapore. This new facility will provide the local research community access to cutting-edge long-read sequencing technology. This initiative marks a milestone for the expanding application of HiFi long-read sequencing in precision medicine, population genomics, and health and disease biology in Southeast Asia. Two PacBio Revio systems will be installed at the lab. PacBio Revio systems are equipped with PacBio’s proprietary HiFi sequencing technology. In addition to supporting the National Precision Medicine long-read sequencing needs, the new joint lab will serve as a resource for Singapore’s research community.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- Cathie Wood’s ARK Investment buys 1.2M shares of PacBio today
- Cathie Wood’s ARK Investment buys 704K shares of PacBio today
- PacBio announces the HiFi Solves Sub-fertility Consortium
- BIOSECURE Act passage would be modest positive for Illumina, says Canaccord
- PacBio announces collaboration with University Hospital of Munster